BRPI0514852A - aperfeiçoamentos para sìnteses, composições farmacêuticas e usos do pentaborato de sódio pentaidratado (nab5o8.5h2o) - Google Patents
aperfeiçoamentos para sìnteses, composições farmacêuticas e usos do pentaborato de sódio pentaidratado (nab5o8.5h2o)Info
- Publication number
- BRPI0514852A BRPI0514852A BRPI0514852-9A BRPI0514852A BRPI0514852A BR PI0514852 A BRPI0514852 A BR PI0514852A BR PI0514852 A BRPI0514852 A BR PI0514852A BR PI0514852 A BRPI0514852 A BR PI0514852A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- syntheses
- refinements
- sodium pentaborate
- nab
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 3
- WUOZWCIWERXVLY-UHFFFAOYSA-N O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] WUOZWCIWERXVLY-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 2
- 235000010338 boric acid Nutrition 0.000 abstract 2
- 229960002645 boric acid Drugs 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 229910021538 borax Inorganic materials 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- YNPKJCSIKJCODK-UHFFFAOYSA-N disodium boric acid hydrogen borate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].OB(O)O.OB(O)O.OB(O)O.OB([O-])[O-] YNPKJCSIKJCODK-UHFFFAOYSA-N 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 235000010339 sodium tetraborate Nutrition 0.000 abstract 1
- 239000004328 sodium tetraborate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
APERFEIçOAMENTOS PARA SìNTESES, COMPOSIçõES FARMACêUTICAS E USOS DO PENTABORATO DE SóDIO PENTAIDRATADO (NaB~ 5~O~ 8~.5H~ 2~O) A invenção refere-se a um método aperfeiçoado para a síntese de pentaborato de sódio pentaidratado (NaB~ 5~O~ 8~.5H~ 2~O), que consiste na reação de tetraborato dissódico decaidratado (DTBD, Bórax) e ácido ortobórico (OBA, ácido bórico). O processo é executado em um período de tempo de não mais do que cinco dias e não exige o emprego de cepas fúngicas. A invenção também se refere a um produto obtido por este método, que se destina a estimular o sistema imune contra enfermidades causadas por bactérias e vírus, a suas composições farmacêuticas e a sua utilização nestas enfermidades.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA04008485A MXPA04008485A (es) | 2004-09-02 | 2004-09-02 | Mejoras a sontesis, composiciones farmaceuticas y usos del pentaborato de sodio pentahidratado (nab5o85 h2o). |
| PCT/MX2005/000079 WO2006025724A1 (es) | 2004-09-02 | 2005-09-02 | MEJORAS A SÍNTESIS, COMPOSICIONES FARMACÉUTICAS Y USOS DEL PENTABORATO DE SODIO PENTAHIDRATADO (NaB5O8.5H2O) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514852A true BRPI0514852A (pt) | 2008-06-24 |
Family
ID=36000319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514852-9A BRPI0514852A (pt) | 2004-09-02 | 2005-09-02 | aperfeiçoamentos para sìnteses, composições farmacêuticas e usos do pentaborato de sódio pentaidratado (nab5o8.5h2o) |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1790349A1 (pt) |
| JP (1) | JP2008511532A (pt) |
| CN (1) | CN101035549A (pt) |
| BR (1) | BRPI0514852A (pt) |
| CA (1) | CA2580695A1 (pt) |
| MX (1) | MXPA04008485A (pt) |
| RU (1) | RU2007111374A (pt) |
| WO (1) | WO2006025724A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014168592A1 (en) | 2013-04-08 | 2014-10-16 | Yeditepe Universitesi | Antiviral gel combination |
| MX394428B (es) * | 2017-06-28 | 2025-03-24 | Juan Pablo Galvan Perez | Composición farmacéutica de pentaborato sódico para incrementar la respuesta de linfocitos t y células nk previamente activados de individuos inmunocompetentes. |
| WO2020018037A2 (en) * | 2018-03-12 | 2020-01-23 | Yeditepe Universitesi | A chemotherapeutic agent comprising a combination of alexidine dihydrochloride and sodium pentaborate pentahydrate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991006304A1 (en) * | 1989-10-31 | 1991-05-16 | American Biotech Resources, Inc. | Synthesis, composition and medical application of cyclic pentaborate compounds |
-
2004
- 2004-09-02 MX MXPA04008485A patent/MXPA04008485A/es active IP Right Grant
-
2005
- 2005-09-02 WO PCT/MX2005/000079 patent/WO2006025724A1/es not_active Ceased
- 2005-09-02 RU RU2007111374/15A patent/RU2007111374A/ru not_active Application Discontinuation
- 2005-09-02 CA CA002580695A patent/CA2580695A1/en not_active Abandoned
- 2005-09-02 JP JP2007529743A patent/JP2008511532A/ja active Pending
- 2005-09-02 BR BRPI0514852-9A patent/BRPI0514852A/pt not_active Application Discontinuation
- 2005-09-02 EP EP05779458A patent/EP1790349A1/en not_active Withdrawn
- 2005-09-02 CN CNA2005800343621A patent/CN101035549A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04008485A (es) | 2006-03-06 |
| CN101035549A (zh) | 2007-09-12 |
| JP2008511532A (ja) | 2008-04-17 |
| RU2007111374A (ru) | 2008-10-10 |
| WO2006025724A1 (es) | 2006-03-09 |
| EP1790349A1 (en) | 2007-05-30 |
| CA2580695A1 (en) | 2006-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1006141B8 (pt) | composições de anticorpo modificado, métodos para preparar e usar as mesmas | |
| ES2122534T3 (es) | Procedimiento para la preparacion de antagonistas de leucotrienos. | |
| ES2421440T3 (es) | Método para preparar ácidos grasos poliinsaturados en plantas transgénicas | |
| ES2124062T3 (es) | Derivados de nucleosido fosforotioato, sintesis y uso de los mismos. | |
| DE602006014148D1 (de) | Verfahren zur herstellung von celluloseregeneratfa | |
| UY29791A1 (es) | Sales novedosas de lisina de derivados de acido 4-( (fenoxialquil)tio)-fenoxiacetico | |
| BRPI0514448A (pt) | derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias | |
| WO2007118159A3 (en) | Use of storage-stable aqueous solutions of chlorine dioxide to generate pure chlorine dioxide gas for decontamination | |
| NZ593882A (en) | Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
| AR087021A1 (es) | Retardador de cemento y metodo para utilizar el mismo | |
| PE20091088A1 (es) | Proceso para la preparacion de medetomidina | |
| BRPI0508704A (pt) | métodos para a preparação de um composto e para a preparação de calcipotriol ou monoidrato de calcipotriol, composto, e, usos de um composto e de éster dietìlico do ácido (2-ciclopropil-2-oxoetil) fosfÈnico | |
| BRPI0514852A (pt) | aperfeiçoamentos para sìnteses, composições farmacêuticas e usos do pentaborato de sódio pentaidratado (nab5o8.5h2o) | |
| ATE488509T1 (de) | Verfahren zur herstellung von substituierten tetrazolen aus aminotetrazolen | |
| CR9565A (es) | Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica | |
| AR087007A2 (es) | Proceso para preparar un derivado tiazolico intermediario en la sintesis de pesticidas de guanidina | |
| CL2004000574A1 (es) | Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion. | |
| FR2968648B1 (fr) | Solutions comprenant un complexe de bore, procede de preparation desdites solutions, leurs utilisations | |
| PE95099A1 (es) | Metodo para producir borato calcico | |
| BR0114251A (pt) | Carbonato de sódio granulado obtido através de granulação por pulverização em leito fluido e um processo para sua produção | |
| AR044944A1 (es) | Procedimiento par la sintesis de perindopril y sales farmaceuticamente aceptables del mismo | |
| BR0209820A (pt) | Processo para a preparação de formulações sólidas de 3-hidróxi-3-metilbutirato de sódio | |
| BR0206574A (pt) | Método para preparar um éter de ácido graxo de um carboidrato por meio de intercâmbio de ésteres entre o carboidrato ou seu derivativo e um éster de ácido graxo | |
| BRPI0413865A (pt) | processo de produção de pó contendo ácido silìcico e sistema de produção de pó contendo ácido silìcico | |
| MXPA03002189A (es) | Mejoras a sintesis, composiciones farmaceuticas y usos del pentaborato de sodio pentahidratado (nab5o8). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |